Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

Subscribe To Our Latest Investor News

News Highlights
April 10, 2021

Combination of copanlisib and rituximab significantly increases progression-free survival in patients with relapsed indolent non-Hodgkin's Lymphoma

READ MORE
April 6, 2021

Bayer to present new clinical data at AACR Annual Meeting 2021

READ MORE
March 23, 2021
Not intended for U.S. and UK Media

Bayer receives approval for Vitrakvi™ in Japan

READ MORE
March 12, 2021

Elections at the Annual Stockholders' Meeting on April 27, 2021

Read more
AD HOC

Discover Bayer’s Latest Ad Hoc Releases

READ MORE
Explore All
51 - 60of about 613 News
51 - 60of about 613 News
August 11, 2020
Not intended for U.S. and UK Media
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd.
READ MORE
August 04, 2020
Second quarter of 2020:
Bayer: Solid performance despite COVID-19 impact
READ MORE
August 03, 2020
Bayer completes the sale of its Animal Health business unit to Elanco
READ MORE
July 16, 2020
Not intended for U.S. and UK Media
U.S. FDA grants priority review to New Drug Application for vericiguat to treat chronic heart failure
READ MORE
July 09, 2020
Not intended for U.S. and UK Media
Bayer’s finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 diabetes
READ MORE
July 08, 2020
Bayer remains committed to Roundup™ settlement
READ MORE
July 01, 2020
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer issues new senior bonds with a volume of 6 billion euros
READ MORE
June 24, 2020
Bayer announces agreements to resolve major legacy Monsanto litigation
READ MORE
June 19, 2020
Women empowerment in times of COVID-19
Bayer supports “The Challenge Initiative” of Johns Hopkins Bloomberg School of Public Health with 10 million USD
READ MORE
June 17, 2020
Bayer to Provide Crop Relief to Two Million Smallholder Farmers Impacted by COVID-19
READ MORE
51 - 60of about 613 News
51 - 60of about 613 News